China Jo-Jo Drugstores Inc
China Jo-Jo Drugstores, Inc. operates as a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, tradition… Read more
China Jo-Jo Drugstores Inc (CJJD) - Net Assets
Latest net assets as of December 2024: $20.12 Million USD
Based on the latest financial reports, China Jo-Jo Drugstores Inc (CJJD) has net assets worth $20.12 Million USD as of December 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($94.19 Million) and total liabilities ($74.07 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $20.12 Million |
| % of Total Assets | 21.36% |
| Annual Growth Rate | 37.88% |
| 5-Year Change | -23.88% |
| 10-Year Change | -17.06% |
| Growth Volatility | 93.96 |
China Jo-Jo Drugstores Inc - Net Assets Trend (2007–2024)
This chart illustrates how China Jo-Jo Drugstores Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for China Jo-Jo Drugstores Inc (2007–2024)
The table below shows the annual net assets of China Jo-Jo Drugstores Inc from 2007 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-03-31 | $14.29 Million | -14.24% |
| 2023-03-31 | $16.67 Million | -26.70% |
| 2022-03-31 | $22.74 Million | -6.82% |
| 2021-03-31 | $24.40 Million | +29.95% |
| 2020-03-31 | $18.78 Million | +10.65% |
| 2019-03-31 | $16.97 Million | -10.03% |
| 2018-03-31 | $18.86 Million | -29.26% |
| 2017-03-31 | $26.66 Million | +38.04% |
| 2016-03-31 | $19.32 Million | +12.08% |
| 2015-03-31 | $17.23 Million | +19.98% |
| 2014-03-31 | $14.36 Million | -62.35% |
| 2013-03-31 | $38.15 Million | -27.13% |
| 2012-03-31 | $52.35 Million | +24.46% |
| 2011-03-31 | $42.06 Million | +152.03% |
| 2010-03-31 | $16.69 Million | +232095.40% |
| 2009-03-31 | $-7.19K | -323.97% |
| 2008-03-31 | $3.21K | -94.71% |
| 2007-03-31 | $60.71K | -- |
Equity Component Analysis
This analysis shows how different components contribute to China Jo-Jo Drugstores Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7350350900.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $418.41K | 2.68% |
| Other Comprehensive Income | $2.31 Million | 14.80% |
| Other Components | $86.41 Million | 552.52% |
| Total Equity | $15.64 Million | 100.00% |
China Jo-Jo Drugstores Inc Competitors by Market Cap
The table below lists competitors of China Jo-Jo Drugstores Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kintavar Exploration Inc
V:KTR
|
$5.94 Million |
|
Ajooni Biotech Limited
NSE:AJOONI
|
$5.94 Million |
|
Times Guaranty Limited
NSE:TIMESGTY
|
$5.94 Million |
|
Sasbadi Holdings Bhd
KLSE:5252
|
$5.94 Million |
|
Viettronics Tan Binh JSC
VN:VTB
|
$5.94 Million |
|
E79 Gold Mines Ltd
AU:E79
|
$5.94 Million |
|
Korea Refract
KO:010040
|
$5.93 Million |
|
GreenMerc AB (publ)
F:L5L
|
$5.93 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in China Jo-Jo Drugstores Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 18,014,011 to 15,640,010, a change of -2,374,001 (-13.2%).
- Net loss of 4,234,228 reduced equity.
- New share issuances of 2,589,600 increased equity.
- Other comprehensive income decreased equity by 729,373.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.23 Million | -27.07% |
| Share Issuances | $2.59 Million | +16.56% |
| Other Comprehensive Income | $-729.37K | -4.66% |
| Total Change | $- | -13.18% |
Book Value vs Market Value Analysis
This analysis compares China Jo-Jo Drugstores Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.14x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 5.48x to 0.14x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-03-31 | $0.28 | $1.52 | x |
| 2008-03-31 | $0.01 | $1.52 | x |
| 2009-03-31 | $0.00 | $1.52 | x |
| 2010-03-31 | $22.19 | $1.52 | x |
| 2011-03-31 | $38.08 | $1.52 | x |
| 2012-03-31 | $46.30 | $1.52 | x |
| 2013-03-31 | $33.71 | $1.52 | x |
| 2014-03-31 | $12.38 | $1.52 | x |
| 2015-03-31 | $13.61 | $1.52 | x |
| 2016-03-31 | $14.35 | $1.52 | x |
| 2017-03-31 | $15.69 | $1.52 | x |
| 2018-03-31 | $8.97 | $1.52 | x |
| 2019-03-31 | $7.53 | $1.52 | x |
| 2020-03-31 | $150.59 | $1.52 | x |
| 2021-03-31 | $151.50 | $1.52 | x |
| 2022-03-31 | $1661.41 | $1.52 | x |
| 2023-03-31 | $35.33 | $1.52 | x |
| 2024-03-31 | $10.83 | $1.52 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently China Jo-Jo Drugstores Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -27.07%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.74%
- • Asset Turnover: 1.63x
- • Equity Multiplier: 6.08x
- Recent ROE (-27.07%) is above the historical average (-224.76%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | -12.31% | 0.00% | 0.00x | 1.00x | $-6.77K |
| 2008 | -1790.04% | 0.00% | 0.00x | 1.00x | $-28.91K |
| 2009 | -1790.04% | 0.00% | 0.00x | 1.00x | $-28.91K |
| 2010 | 58.85% | 17.80% | 2.29x | 1.45x | $8.15 Million |
| 2011 | 20.05% | 12.05% | 1.30x | 1.28x | $4.23 Million |
| 2012 | 15.55% | 8.63% | 1.26x | 1.43x | $2.91 Million |
| 2013 | -37.57% | -16.02% | 1.32x | 1.78x | $-18.15 Million |
| 2014 | -177.03% | -38.33% | 1.44x | 3.21x | $-26.79 Million |
| 2015 | 4.98% | 1.11% | 1.29x | 3.46x | $-862.88K |
| 2016 | 2.31% | 0.50% | 1.43x | 3.21x | $-1.48 Million |
| 2017 | -21.17% | -6.93% | 1.21x | 2.52x | $-8.31 Million |
| 2018 | -90.44% | -17.75% | 1.30x | 3.91x | $-18.95 Million |
| 2019 | -7.25% | -1.23% | 1.48x | 4.00x | $-3.13 Million |
| 2020 | -31.36% | -5.50% | 1.18x | 4.83x | $-8.52 Million |
| 2021 | -32.54% | -6.29% | 1.25x | 4.13x | $-10.95 Million |
| 2022 | -13.28% | -1.95% | 1.55x | 4.42x | $-5.61 Million |
| 2023 | -117.35% | -14.21% | 1.64x | 5.05x | $-22.94 Million |
| 2024 | -27.07% | -2.74% | 1.63x | 6.08x | $-5.80 Million |
Industry Comparison
This section compares China Jo-Jo Drugstores Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $262,812,914
- Average return on equity (ROE) among peers: -4.74%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| China Jo-Jo Drugstores Inc (CJJD) | $20.12 Million | -12.31% | 3.68x | $5.94 Million |
| Alibaba Health Information Technology Limited (ALBBY) | $1.12 Billion | -18.54% | 0.50x | $12.50 Billion |
| Allstar Health Brands Inc (ALST) | $-9.92 Million | 0.00% | 0.00x | $3.83 |
| Bimi International Medical Inc (BIMI) | $-409.66K | 0.00% | 0.00x | $296.83 |
| Blum Holdings Inc (BLMH) | $-4.74 Million | 0.00% | 0.00x | $8.97 Million |
| Clicks Group Ltd (CLCGY) | $1.13 Billion | 41.98% | 2.72x | $4.80 Billion |
| China BCT Pharmacy Group Inc (CNBI) | $134.27 Million | 15.68% | 0.82x | $0.96 |
| Dalrada Financial Corp (DFCO) | $4.40 Million | -81.82% | 0.55x | $1.57 Million |
| Health Advance Inc (HADV) | $-105.34K | 0.00% | 0.00x | $25.40K |
| Healthwarehouse.Com (HEWA) | $-3.10 Million | 0.00% | 0.00x | $720.96 |